Loading stock…

Daiichi Sankyo Company, Limited (4568) Stock Verdict & Ratings | Investment Bastion

Stock Verdict·Updated 1d ago

Daiichi Sankyo Company, Limited

4568Market cap $32BPrice $17.2

Country🇯🇵Japan

SectorHealthcare

IndustryPharmaceuticals

Develops cancer and cardiovascular drugs, including a blockbuster antibody-drug conjugate partnered with AstraZeneca that's reshaping how doctors target tumors. One of Japan's oldest drugmakers, it's now betting big on precision oncology to fuel global growth.

In Bastion Portfolios?

52W Return-34%Global Market +16%?

01Key Ratings

How does this stock score across Bastion factors?

Growth

Historical Revenue

Rev CAGR (3y)+12%7

Revenue Forecast

Rev CAGR (1y)+12%6

Rev CAGR (3y)+7%5

Rev CAGR (5y)+8%7

Earnings Forecast

EPS Growth Y+1+56%9

EPS Growth Y+2+5%5

EPS Growth Y+3+11%7

Quality

Margins

EBIT Marginna–

Net Income Margin12%6

Free Cash Flow Margin-0%3

Debt

Net Debt/EBITDAna–

Efficiency

ROE16%7

ROA7%7

Earnings Stability88

GEAR+WEAK27

Overall rating across all five factors

Value

Price Multiples

P/E Ratio (Forward)127

P/E Ratio (Forward 3y)117

P/BV2.95

EV Multiples

EV/EBITDA Fwd115

EV/EBIT Fwd146

Yield

Free Cash Flow Yield-0.0%3

Dividend Yieldna–

Momentum

Short term

1 month return+2%8

3 month return+2%7

YTD return-16%3

Mid term

Price vs 52wHigh67%3

1 year return-29%2

Long term

3 year return-26%1

5 year return+3%4

Risk Shield

Price Risk

Betana–

Volatility38%5

Free Cash Flow

Free Cash Flow Margin-0%3

Free Cash Flow Yield-0.0%3

Quality

ROCE8%5

Earnings Stability88

Net Debt/EBITDAna–

02Growth

Is it actually growing, and how fast?

4568Daiichi Sankyo Company

Revenue FY26$13.4B

GROWTH RATING↗

AVERAGE59 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+12%7

Revenue, next 1Y+12%6

Revenue, next 3Y, CAGR+7%5

Revenue, next 5Y, CAGR+8%7

EARNINGS FORECAST▾SCORE

EPS growth, FY27E+56%9

EPS growth, FY28E+5%5

EPS growth, FY29E+11%7

GROWTH ASSESSMENT

STRENGTHS

Revenue grew 12%/yr over the last 3 years, ahead of 60% of companies worldwide.7/10

The runway holds up: revenue is set to grow 8%/yr over five years.7/10

Earnings are set to grow in step with sales (EPS about 11%/yr vs revenue 7%/yr).

WATCH

A mid-pack grower, ahead of 59% of companies worldwide.

Revenue is set to grow 7%/yr over the next 3 years, a little ahead of the market.6/10

Revenue grew 12%/yr over the last 3 years; forecasts see it cooling to 7%/yr.

WEAKNESSES

None flagged.

BOTTOM LINE

Maturing Grower

A middle-of-the-pack grower that is slowing. The one thing to watch: the pace is cooling.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

WEAK28 / 100

SHORT-TERM RETURNS▾SCORE

1-month return+2%8

3-month return+2%7

YTD return-16%3

MID & LONG-TERM▾SCORE

% of 52-week high67%3

1-year return-29%2

3-year return-26%1

5-year return+3%4

MOMENTUM ASSESSMENT

STRENGTHS

Strong recent results. The stock is outperforming over the past month (+2%) and over three months (+2%).

WATCH

None flagged.

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (-26% over three years and +2.5% over five), behind 70% of the market.

It's down 29% over the past year, now 33% below its 52-week high. That is lagging the market.

The stock is underperforming so far this year (-16%).

BOTTOM LINE

Early Turnaround

A poor multi-year track record but a sharp recent rally. Momentum is turning up, yet the trend is young and unproven — it needs follow-through to confirm rather than fade. The one thing to watch: the multi-year record is weak.

04Value

Are you paying a fair price for it?

Stop guessing on Daiichi Sankyo. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

4568Daiichi Sankyo Company

Revenue FY26$13.4B

GROWTH RATING↗

AVERAGE59 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+12%7

Revenue, next 1Y+12%6

Revenue, next 3Y, CAGR+7%5

Revenue, next 5Y, CAGR+8%7

EARNINGS FORECAST▾SCORE

EPS growth, FY27E+56%9

EPS growth, FY28E+5%5

EPS growth, FY29E+11%7

GROWTH ASSESSMENT

STRENGTHS

Revenue grew 12%/yr over the last 3 years, ahead of 60% of companies worldwide.7/10

The runway holds up: revenue is set to grow 8%/yr over five years.7/10

Earnings are set to grow in step with sales (EPS about 11%/yr vs revenue 7%/yr).

WATCH

A mid-pack grower, ahead of 59% of companies worldwide.

Revenue is set to grow 7%/yr over the next 3 years, a little ahead of the market.6/10

Revenue grew 12%/yr over the last 3 years; forecasts see it cooling to 7%/yr.

WEAKNESSES

None flagged.

BOTTOM LINE

Maturing Grower

A middle-of-the-pack grower that is slowing. The one thing to watch: the pace is cooling.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

WEAK28 / 100

SHORT-TERM RETURNS▾SCORE

1-month return+2%8

3-month return+2%7

YTD return-16%3

MID & LONG-TERM▾SCORE

% of 52-week high67%3

1-year return-29%2

3-year return-26%1

5-year return+3%4

MOMENTUM ASSESSMENT

STRENGTHS

Strong recent results. The stock is outperforming over the past month (+2%) and over three months (+2%).

WATCH

None flagged.

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (-26% over three years and +2.5% over five), behind 70% of the market.

It's down 29% over the past year, now 33% below its 52-week high. That is lagging the market.

The stock is underperforming so far this year (-16%).

BOTTOM LINE

Early Turnaround

04Value

Are you paying a fair price for it?

Stop guessing on Daiichi Sankyo. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community